Healthcare Sales & Marketing Network News: cystic fibrosis

Searching News Database: cystic fibrosis

HSMN NewsFeed - 6 Mar 2024
Sionna Therapeutics Announces $182 Million Series C Financing to Advance Clinical Development of Novel Small Molecules in Cystic Fibrosis
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 24 Jan 2024
ZWI Therapeutics, Inc. Announces a Series A Financing, Two Accomplished Biopharmaceutical CEOs Join the Board of Directors, and Appointment of Chief Executive Officer
Biopharmaceuticals Personnel Venture Capital

HSMN NewsFeed - 18 Jul 2023
Flagship Pioneering and Pfizer Partner to Accelerate Development of Innovative Medicines Targeting Unmet Needs
Biopharmaceuticals

HSMN NewsFeed - 1 Aug 2022
Armata Pharmaceuticals Announces Clearance of IND for Prosthetic Joint Infections
Biopharmaceuticals FDA

HSMN NewsFeed - 19 May 2022
Odyssey Therapeutics Appoints Industry Leader Jeffrey M. Leiden, M.D., Ph.D., as Board Chair
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 3 Feb 2022
Third Pole Therapeutics Closes $25M Financing - eNOfit(TM) Wearable Device Now Ready for Clinical Trials
Devices Venture Capital

HSMN NewsFeed - 24 May 2021
Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19
Regenerative Medicine Licensing

HSMN NewsFeed - 13 May 2021
SpliSense Secures $28.5 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Apr 2021
Third Pole Therapeutics Secures $15 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
Devices Venture Capital

HSMN NewsFeed - 30 Dec 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Final Results of BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals

HSMN NewsFeed - 27 Nov 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Extension of PDUFA Date for Pegunigalsidase Alfa for the Proposed Treatment of Fabry Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Oct 2020
Armata Pharmaceuticals Appoints Mina Pastagia, MD, MS as Vice President of Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Aug 2020
Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 24 Jul 2020
Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infections Caused by MAC in Non-CF Patients with Limited Treatment Options
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 15 Jun 2020
Aridis Pharmaceuticals Appoints Dr. Hasan Jafri as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jun 2020
Insmed Receives FDA Breakthrough Therapy Designation for Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE)
Biopharmaceuticals FDA

HSMN NewsFeed - 28 May 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Submission of Biologics License Application to U.S. Food and Drug Administration for Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 25 May 2020
4DMedical's Lung Imaging Technology Receives FDA Clearance as COVID-19 Intensifies Global Focus on Respiratory Health
Diagnostics Radiology FDA

HSMN NewsFeed - 13 May 2020
Spirovant Sciences Appoints Roland Kolbeck, PhD, as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 May 2020
Protalix BioTherapeutics Announces Positive Topline Results from the BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals

HSMN NewsFeed - 8 Apr 2020
Third Pole Therapeutics Announces Global Commercialization Agreement with Chiesi Group for Its Tankless, Portable Inhaled Nitric Oxide (iNO) Delivery System
Biopharmaceuticals Licensing

HSMN NewsFeed - 2 Apr 2020
Insmed Appoints Carol A. Schafer to its Board of Directors
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 30 Jan 2020
Insmed Appoints Sara Bonstein as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jan 2020
Aridis Pharmaceuticals Appoints Michael A. Nazak as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Dec 2019
Protalix BioTherapeutics Adds Two Accomplished Biopharmaceutical Executives to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Oct 2019
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Sep 2019
AskBio Acquires Assets from RoverMed BioSciences, Adds Nanotechnology Precision to Delivery of AAV Gene Therapeutics
Biopharmaceuticals Drug Delivery Acquisitions

HSMN NewsFeed - 30 Jul 2019
Aridis Pharmaceuticals Enters Into Equity Purchase and Option Agreements with The Serum Institute of India, Ltd for Exclusive License to Products and MabIgX(R) Platform Technology
Biopharmaceuticals Licensing

HSMN NewsFeed - 23 Jul 2019
Proteostasis Therapeutics Announces Management Changes and Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jul 2019
Aridis Pharmaceuticals Receives Orphan Drug Designation From the European Medicines Agency for AR-501
Biopharmaceuticals Regulatory

HSMN NewsFeed - 10 Jun 2019
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 May 2019
Proteostasis Therapeutics Appoints Dr. Badrul Chowdhury, Former FDA Director of Pulmonology, Allergy, and Rheumatology, to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Mar 2019
Synspira Therapeutics Announces Appointment of Robert Gallotto as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Mar 2019
Proteostasis Therapeutics Appoints David Arkowitz to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Feb 2019
Proteostasis Therapeutics Appoints Emmanuel Dulac and Kim Drapkin to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jan 2019
ArcherDX Acquires Baby Genes, a Genetics-Based Personalized Medicine Company
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 17 Dec 2018
Proteostasis Therapeutics Announces Global License Agreement with Genentech
Biopharmaceuticals Licensing

HSMN NewsFeed - 5 Dec 2018
Vast Therapeutics Announces Series A Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 11 Jun 2018
Neovasc Announces Appointment of Steve Rubin as Chairman of the Board and General Update
Devices Cardiology Personnel

HSMN NewsFeed - 4 Apr 2018
Proteostasis Therapeutics Receives FDA Fast Track Designation for Triple Combination Program in Patients with Cystic Fibrosis
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Mar 2018
Aridis Pharmaceuticals, Inc. Appoints Wolfgang Dummer, M.D., Ph.D., as Chief Medical Officer, and Mitchell H. Rosner, Ph.D. as Vice President of Quality
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 5 Feb 2018
FDA Clears Oricula Therapeutics Investigational New Drug Application for Clinical Trials
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Feb 2018
Appointment of Jonathan E. Gold as Interim Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Dec 2017
Protalix BioTherapeutics’ PRX-102 Granted Orphan Drug Designation by the European Commission
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 Oct 2017
KNOW Bio Strengthens Leadership with the Addition of Four New Board Members
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Sep 2017
Eloxx Pharmaceuticals Expands Management Team to Support Rapid Development of Lead Drug Candidate ELX-02 for the Treatment of Rare Genetic Diseases
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Sep 2017
Pulmatrix Licenses Inhaled COPD Drug PUR0200 to Vectura Group plc
Biopharmaceuticals Licensing

HSMN NewsFeed - 2 Aug 2017
Eloxx Pharmaceuticals Secures US$8 Million Investment from LSP, Increasing Total Raised in Series C to US$38 Million
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Jul 2017
Quest Diagnostics Launches QHerit(TM), a Pan-Ethnic Genetic Screening Panel Aligned with New Medical Guidelines
Diagnostics Product Launch

HSMN NewsFeed - 5 Jun 2017
Novoteris, LLC Receives FDA and Health Canada Clearance to Start a Phase 2 Clinical Trial of Its Thiolanox(R) Nitric Oxide for the Treatment of Cystic Fibrosis
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 8 May 2017
Lamellar Biomedical Raises £5.75 Million in Series C Fund Raising led by Invesco
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 1 May 2017
Shire and Parion Sciences Enter into a Collaborative License Agreement to Advance P-321 for Ophthalmic Indications
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 11 Apr 2017
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 18 Oct 2016
Corbus Pharmaceuticals Receives Orphan Designation for Resunab for the Treatment of Cystic Fibrosis in the European Union
Biopharmaceuticals Regulatory

HSMN NewsFeed - 5 Oct 2016
Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor
Biopharmaceuticals Licensing

HSMN NewsFeed - 15 Jul 2016
Bach Pharma Appoints Kelly Blackburn as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jun 2016
Savara Pharmaceuticals Acquires Serendex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 10 Jun 2016
Raptor Pharmaceutical Announces Presentation of New Data Analyses from a Phase 3 Study of QUINSAIR(TM) at the 39th European Cystic Fibrosis Conference
Biopharmaceuticals

HSMN NewsFeed - 29 Apr 2016
Allergan Receives CHMP Positive Opinion For ENZEPI(R) (Pancrelipase) For Patients With Exocrine Pancreatic Insufficiency (EPI)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 13 Apr 2016
Oculus Innovative Sciences Receives European Approval to Market Sinudox(TM) Indicated for Use in Nasal Irrigation
Biopharmaceuticals Regulatory

HSMN NewsFeed - 7 Mar 2016
Anthera Pharmaceuticals Announces Appointment of Dr. James Pennington as Interim Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Mar 2016
Savara Pharmaceuticals Completes $20 Million Round of Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 29 Feb 2016
Genentech Provides Update On Two Identical Phase III Studies Of Lebrikizumab In People With Severe Asthma
Biopharmaceuticals

HSMN NewsFeed - 23 Feb 2016
PTC Receives Refuse to File Letter from FDA for Translarna(TM) (ataluren)
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Feb 2016
Proteostasis Therapeutics Receives FDA Fast Track Designation for PTI-428 in Patients With Cystic Fibrosis
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Jan 2016
Monaghan Medical Introduces Manometer Adapter to Measure Treatment With Aerobika(R) OPEP Device
Devices Product Launch

HSMN NewsFeed - 13 Jan 2016
Galapagos and Gilead Cleared by U.S. Federal Trade Commission to Close Global Partnership on Filgotinib
Biopharmaceuticals

HSMN NewsFeed - 23 Dec 2015
VistaGen Secures Exclusive Worldwide Commercial Rights to Three Proprietary Stem Cell Technologies from University Health Network
Biopharmaceuticals Regenerative Medicine Licensing

HSMN NewsFeed - 17 Dec 2015
Galapagos and Gilead Announce Global Partnership to Develop Filgotinib for the Treatment of Rheumatoid Arthritis and Other Inflammatory Diseases
Biopharmaceuticals

HSMN NewsFeed - 8 Dec 2015
Pulmatrix Appoints Mark Iwicki Chairman of the Board
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 23 Nov 2015
Vertex Appoints Michael J. Parini as Executive Vice President and Chief Legal Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Oct 2015
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
Biopharmaceuticals Gastroenterology Acquisitions

HSMN NewsFeed - 15 Oct 2015
Third Rock Ventures Launches Decibel Therapeutics with $52 Million Series A Financing to Discover New Medicines to Protect, Repair and Restore Hearing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 29 Sep 2015
Audentes Therapeutics Expands Senior Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Jul 2015
aTyr Pharma Announces Transitions In Clinical Development & Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jun 2015
Pulmatrix Appoints William Duke, Jr., as Chief Financial Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 1 May 2015
Advanced Inhalation Therapies Granted European Orphan Drug Designation for Nitric Oxide for the Treatment of Cystic Fibrosis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 3 Dec 2014
PTC Therapeutics Announces Launch of Translarna(TM) (ataluren) in Germany
Biopharmaceuticals Product Launch

HSMN NewsFeed - 23 Oct 2014
Raptor Pharmaceutical Announces Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Sep 2014
NovaBiotics Receives Orphan Drug Status from the US Food and Drug Administration (FDA) for Lynovex(R) for the Treatment of Cystic Fibrosis
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Aug 2014
Akebia Therapeutics Announces Expansion of Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Jul 2014
Vertex Announces Retirement of Peter Mueller, Ph.D.
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jun 2014
Proteostasis Therapeutics Appoints Meenu Chhabra as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2014
Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor) in Eight Non-G551D Gating Mutations
Biopharmaceuticals Regulatory

HSMN NewsFeed - 27 Jun 2014
Protalix Announces New Data on ELELYSO(TM) (taliglucerase alfa) Presented at the European Working Group on Gaucher Disease 2014 11th Meeting
Biopharmaceuticals

HSMN NewsFeed - 15 Apr 2014
AAVLife Raises $12 Million in Series A Financing to Advance Gene Therapy for Friedreich’s Ataxia
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 13 Mar 2014
Synergy Pharmaceuticals Appoints Marino Garcia as Senior Vice President, Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Feb 2014
CURx Pharmaceuticals Announces License Agreement with Gilead Sciences
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 18 Feb 2014
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 2 Feb 2014
Forest Laboratories, Inc. Files Lawsuit Against Several Companies for Infringement of NAMENDA XR(R) Patents
Biopharmaceuticals Neurology Generics Litigation

HSMN NewsFeed - 14 Jan 2014
Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands Business Units
Biopharmaceuticals Urology Gastroenterology Personnel

HSMN NewsFeed - 8 Jan 2014
Vertex Announces Appointment of Jeffrey A. Chodakewitz, M.D., as Chief Medical Officer and Senior Vice President of Global Medicines Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jan 2014
Forest Laboratories to Acquire Aptalis for $2.9 Billion in Cash
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 7 Jan 2014
KaloBios Appoints Harry Lam, Ph.D. as Head of Manufacturing
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Dec 2013
Electromed, Inc. Receives FDA Market Clearance for the SmartVest(R) SQL(TM)
Devices FDA

HSMN NewsFeed - 5 Dec 2013
Savara Pharmaceuticals Appoints Two New Members to Its Board of Directors
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 21 Nov 2013
Eloxx Pharmaceuticals, Ltd. Announced the Initial Closing of its First Round of Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 20 Nov 2013
Vertex Sells INCIVO(R) Product Royalty Rights for $152 Million
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 15 Nov 2013
Germ-Zapping Robots Use Xenex’s Powerful, Pulsed UV Light to Improve Patient Safety at University Hospital
Devices

HSMN NewsFeed - 28 Oct 2013
Arcturus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Oct 2013
Celsus Therapeutics Announces Appointment of Pablo Jimenez, M.D., to Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Sep 2013
Aptalis Pharma(TM) Launches PYLERA(R) 10 Day Therapy PAK in the United States
Biopharmaceuticals Gastroenterology Product Launch

HSMN NewsFeed - 28 Aug 2013
Grifols and Aradigm Corporation Complete the Closing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin(R)
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 1 Jul 2013
Illumina Applies CE Mark to MiSeqDx(TM) Cystic Fibrosis System
Diagnostics Regulatory

HSMN NewsFeed - 22 May 2013
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personalized Medicine Personnel

HSMN NewsFeed - 9 May 2013
Cornerstone Therapeutics Acquires Exclusive U.S. Marketing Rights to PERTZYE(R) (pancrelipase) for Treatment of Exocrine Pancreatic Insufficiency in Patients With Cystic Fibrosis
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 7 Mar 2013
PTC Therapeutics Closes $60 Million Private Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 28 Feb 2013
Kala Pharmaceuticals Secures $11.5 Million in Series A Financing
Biopharmaceuticals Drug Delivery Venture Capital

HSMN NewsFeed - 2 Jan 2013
FDA Approves Fulyzaq(TM) (Crofelemer) 125 mg Delayed-Release Tablets for the Symptomatic Relief of Diarrhea in Patients with HIV/AIDS on Anti-Retroviral Therapy (ART)
Biopharmaceuticals FDA HIV/AIDS

HSMN NewsFeed - 28 Nov 2012
NanoBio(R) Closes $11 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Nov 2012
Constella(R) (linaclotide) Approved in Europe for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 7 Nov 2012
Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 26 Oct 2012
NICE Approves Pharmaxis' Bronchitol(R) As An Important New Treatment Option For Cystic Fibrosis Patients
Biopharmaceuticals Regulatory

HSMN NewsFeed - 9 Oct 2012
NanoBio(R) Promotes David Peralta to Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 28 Sep 2012
PTC Therapeutics Appoints Jerome B. Zeldis, M.D., Ph.D. to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Sep 2012
Third Rock Ventures Launches MyoKardia with $38 Million to Address Genetic Heart Disease
Personalized Medicine Cardiology Venture Capital

HSMN NewsFeed - 12 Sep 2012
GenMark Diagnostics Receives FDA Clearance for RVP Test
Diagnostics FDA

HSMN NewsFeed - 11 Sep 2012
Insmed Appoints Will Lewis as President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 4 Sep 2012
Vertex Announces Appointment of Stuart A. Arbuckle as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Sep 2012
Pulmatrix Appoints Robert Clarke, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Aug 2012
Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Jul 2012
Jeff Cooper Joins KaloBios as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jun 2012
GenMark Diagnostics Appoints Stephen T. Worland, Ph.D. to Board of Directors
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 25 May 2012
Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 16 Apr 2012
Insmed Announces First Patient Dosed in Pivotal European Phase 3 Clinical Study of ARIKACE(R) in Cystic Fibrosis Patients with Pseudomonas Lung Infections
Biopharmaceuticals

HSMN NewsFeed - 27 Mar 2012
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Mar 2012
Kala Pharmaceuticals Secures $6.2 Million in Additional Equity Financing
Biopharmaceuticals Drug Delivery Venture Capital

HSMN NewsFeed - 6 Mar 2012
Islet Sciences Names Dr. George J. Todaro and Dr. Jerry L. Nader to Board of Directors
Regenerative Medicine Endocrinology Personnel

HSMN NewsFeed - 24 Feb 2012
Forest Laboratories Receives European Marketing Approval for Colobreathe(R) Dry Powder Inhaler
Biopharmaceuticals Regulatory

HSMN NewsFeed - 16 Feb 2012
GenMark Diagnostics Appoints Dr. Jorge Garces Senior Vice President, Research and Development
Diagnostics Personnel

HSMN NewsFeed - 20 Jan 2012
Insmed Incorporated Provides Corporate Update
Biopharmaceuticals

HSMN NewsFeed - 15 Aug 2011
Pulmatrix Invests in Clinical Programs in COPD and Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 15 Aug 2011
Pulmatrix Secures a $14 million Financing to Advance Clinical Programs in COPD and Cystic Fibrosis
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 29 Jun 2011
Pulmatrix Promotes Robert Clarke, PhD, to Chief Scientific Officer and Vice President of Research and Development
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 20 Jun 2011
Pulmatrix Launches iSPERSE(TM), A Novel Inhaled Dry Powder Drug Delivery Platform
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 25 May 2011
NanoBio(R) Appoints Peter Ulrich to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 May 2011
FDA Approves INCIVEK(TM) (telaprevir) for People with Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Apr 2011
Mpex Pharmaceuticals, Inc. to be Acquired by Axcan
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 12 Apr 2011
DARA BioSciences Reports That SurgiVision Has Completed a Commercial Alliance With Brainlab AG
Biopharmaceuticals Devices Drug Delivery

HSMN NewsFeed - 6 Apr 2011
GenMark Diagnostics Appoints Hany Massarany President and Chief Executive Officer
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 22 Mar 2011
Synergy Pharmaceuticals Appoints Dr. Laura Barrow as Vice President of Clinical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Mar 2011
Quest Diagnostics to Acquire Celera, Strengthening Position as World's Leading Innovator in Molecular Diagnostics and Development
Diagnostics Personalized Medicine Mergers & Acquisitions

HSMN NewsFeed - 17 Mar 2011
KaloBios Announces Two Significant Additions to Its Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Feb 2011
Inspire Announces Corporate Restructuring and Strategic Focus on Eye Care Business
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 12 Jan 2011
Eurand Announces Agreement With Nycomed for ZENPEP(R) in Russia-CIS
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 11 Jan 2011
SUMAVEL DosePro Receives Marketing Approval in Germany and the United Kingdom
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 3 Jan 2011
Inspire Announces Results of Second Phase 3 Trial with Denufosol for Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 14 Dec 2010
Pulmatrix Names Eva Jack as Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 13 Dec 2010
Inspire Announces Launch of DIQUASTM by Santen in Japan
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 6 Oct 2010
FDA Approves Pharmaxis' ARIDOL (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
Biopharmaceuticals Diagnostics FDA

HSMN NewsFeed - 17 Sep 2010
Aradigm Presents Results Supporting Once-Daily Dosing With Its Inhaled Liposomal Ciprofloxacin Formulations at the 2010 European Respiratory Society (ERS) Annual Congress
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 1 Sep 2010
Pfizer to Acquire FoldRx Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 Sep 2010
Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Aug 2010
Inspire Names Dr. Charles Johnson as Executive Vice President of Research and Development and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Aug 2010
Phase 3 ILLUMINATE Study Supports 24-Week Telaprevir-Based Therapy Within a Response-Guided Regimen for People with Hepatitis C Who Had Not Received Prior Treatment
Biopharmaceuticals

HSMN NewsFeed - 2 Jul 2010
Lilly to Acquire Alnara Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 16 Jun 2010
Eurand Names Former Solvay Executive Jean-Louis Anspach President of U.S. Pharmaceuticals Business
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jun 2010
Centocor Ortho Biotech Inc. Acquires RespiVert Ltd., Strengthens Pulmonary Focus
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 May 2010
FoldRx Pharmaceuticals Appoints Dr. Georges Gemayel as Executive Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 May 2010
Abbott Receives FDA Approval for CREON(R) to Include Dosing Information for Patients With Chronic Pancreatitis and Pancreatectomy
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Apr 2010
Osmetech plc Receives 510(k) Clearance for the eSensor(R) Thrombophilia Risk Test
Diagnostics FDA

HSMN NewsFeed - 13 Apr 2010
FDA Approves New Drug Application for PANCREAZE(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Apr 2010
Inspire Appoints Andrew Koven as Executive Vice President and Chief Administrative and Legal Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Mar 2010
FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 1 Mar 2010
Inspire Elects George Abercrombie to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Feb 2010
Inspire Names Adrian Adams as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Feb 2010
Abbott Completes Acquisition of Solvay Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 28 Jan 2010
Alnara Pharmaceuticals Secures $35 Million in Series B Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Jan 2010
PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy
Biopharmaceuticals

HSMN NewsFeed - 16 Dec 2009
GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment
Biopharmaceuticals Licensing

HSMN NewsFeed - 10 Dec 2009
Vertex Pharmaceuticals Announces Appointment of Nancy J. Wysenski as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Nov 2009
Phase II/III Clinical Study Compares Safety and Efficacy of Two Doses of ZENPEP(TM) (Pancrelipase) Delayed-Release Capsules for Fat Absorption in Adult Chronic Pancreatitis Patients With Exocrine Pancreatic Insufficiency
Biopharmaceuticals

HSMN NewsFeed - 4 Nov 2009
Inspire Completes Patient Enrollment in Three Late-Stage Clinical Trials in Cystic Fibrosis, Dry Eye and Blepharitis
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 3 Nov 2009
Alnara Pharmaceuticals Announces Appointment of Lee R. Brettman, M.D., FACP, to Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Sep 2009
Abbott to Acquire Solvay Pharmaceuticals Business
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 15 Sep 2009
Forest Laboratories UK Ltd Submits Marketing Authorisation Application for the First Dry Powder Inhalation Antibiotic for Cystic Fibrosis Patients
Biopharmaceuticals

HSMN NewsFeed - 10 Sep 2009
PTC Therapeutics Initiates Registration-Directed Phase 3 Trial of Ataluren in Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 3 Sep 2009
Luminex Receives 510(K) Clearance for New Cystic Fibrosis Test
Diagnostics FDA

HSMN NewsFeed - 28 Aug 2009
Eurand Granted FDA Approval for ZENPEP(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Jul 2009
FDA Clears Osmetech's Cystic Fibrosis Genotyping Test
Diagnostics FDA

HSMN NewsFeed - 8 Jul 2009
NanoBio Announces Closing of $22 Million Series B Financing Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 Jun 2009
FDA Extends Review Period for Eurand's ZENPEP(TM) Pancreatic Enzyme Replacement Therapy
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 9 Jun 2009
William Aliski Named FoldRx Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Apr 2009
Mpex Pharmaceuticals Names Mark Wiggins Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Apr 2009
EPIX Pharmaceuticals Announces Sale of U.S., Canadian and Australian Rights for MS-325 (formerly marketed as Vasovist, gadofosveset trisodium, by Bayer Schering Pharma) to Lantheus Medical Imaging, Inc.
Biopharmaceuticals Radiology Acquisitions

HSMN NewsFeed - 19 Mar 2009
European CHMP Adopts Negative Opinion on Aztreonam Lysine
Biopharmaceuticals Regulatory

HSMN NewsFeed - 5 Mar 2009
EPIX Pharmaceuticals Appoints Elkan Gamzu, Ph.D., as Permanent CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Feb 2009
EPIX Pharmaceuticals Announces Resignation of Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Feb 2009
Gilead Receives Response From U.S. FDA on Company's Request for Formal Dispute Resolution for Aztreonam for Inhalation Solution
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 18 Feb 2009
NanoBio Corporation Raises $12 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 10 Feb 2009
Mpex Pharmaceuticals Announces Series D Financing of Up to $40 Million
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 30 Jan 2009
Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 29 Jan 2009
FDA Accepts Eurand's Response to Approvable Letter for EUR-1008 as Complete
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jan 2009
Hydra Biosciences Raises $22 Million in Series D Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 Dec 2008
EPIX Pharmaceuticals Announces FDA Approval of Vasovist(R) (gadofosveset trisodium)
Biopharmaceuticals Radiology

HSMN NewsFeed - 22 Dec 2008
KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 Oct 2008
EPIX Pharmaceuticals Announces Reduction in Force
Biopharmaceuticals

HSMN NewsFeed - 23 Sep 2008
KaloBios Raises $20 Million in Series D Venture Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 4 Sep 2008
EPIX Pharmaceuticals To Regain Full Worldwide Commercial Rights For Vasovist(R)
Biopharmaceuticals Radiology

HSMN NewsFeed - 3 Sep 2008
MAP Pharmaceuticals Appoints Alan H. Cohen, M.D., as Vice President, Clinical Development and Medical Affairs, Pulmonary
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jul 2008
EPIX Pharmaceuticals Announces Resignation of CEO; Names Elkan Gamzu Interim CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jul 2008
FDA Clears Osmetech's Warfarin Sensitivity Test and New eSensor(R) XT-8 Platform
Diagnostics FDA

HSMN NewsFeed - 10 Jul 2008
EPIX Pharmaceuticals Announces South Korean Approval of Vasovist(R); Novel Contrast Agent Now Approved for Marketing in 34 Countries
Biopharmaceuticals Radiology Regulatory

HSMN NewsFeed - 1 Jul 2008
EPIX Pharmaceuticals Announces Resubmission of New Drug Application for Vasovist(R)
Biopharmaceuticals

HSMN NewsFeed - 18 Jun 2008
Vertex Pharmaceuticals Announces the Appointment of Freda C. Lewis-Hall, M.D., as Executive Vice President, Medicines Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jun 2008
GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections
Biopharmaceuticals

HSMN NewsFeed - 13 Jun 2008
Gilead Announces Interim 12-Month Phase III Study Results for Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 9 Jun 2008
Hologic to Acquire Third Wave Technologies
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 6 Jun 2008
Inspire Announces Achievement of Primary Endpoint in Phase 3 Trial with Denufosol for Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 3 Jun 2008
Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
Diagnostics Cardiology

HSMN NewsFeed - 3 Jun 2008
Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 30 Apr 2008
Aradigm Announces Data Showing No Occurrence of Primary Lung Cancer in Patients Treated with AERx(R) Insulin Diabetes Management System (iDMS)
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 26 Mar 2008
Breathe Technologies, Inc. Closes on $15 Million in Venture Funding Led by Kleiner Perkins Caufield & Byers
Devices Venture Capital

HSMN NewsFeed - 17 Mar 2008
Hollis-Eden Pharmaceuticals Provides Update on Clinical Development Program; Announces Fourth Quarter and Year-End 2007 Financial Results
Biopharmaceuticals

HSMN NewsFeed - 7 Mar 2008
Gilead Sciences Submits Marketing Authorisation Application for Aztreonam Lysine 75 mg Powder for Nebuliser Solution, a Potential New Treatment for Cystic Fibrosis, to European Medicines Agency
Biopharmaceuticals Regulatory

HSMN NewsFeed - 29 Jan 2008
KaloBios Strengthens Development Expertise With Additions to Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jan 2008
Inspire Announces Its Termination of Bilastine Licensing Agreement
Biopharmaceuticals Licensing

HSMN NewsFeed - 20 Dec 2007
Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Dec 2007
Hollis-Eden Pharmaceuticals Announces Cystic Fibrosis Foundation Therapeutics Selects TRIOLEX(TM) (HE3286) as a Next-Generation Oral Anti-Inflammatory Drug Candidate
Biopharmaceuticals

HSMN NewsFeed - 17 Dec 2007
PARI Hydrate Receives FDA Clearance
Devices FDA

HSMN NewsFeed - 4 Dec 2007
Pharmaxis Commences Operations in United States
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Dec 2007
Eurand Acquires Specialty Cystic Fibrosis Company
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 19 Nov 2007
APT Pharmaceuticals Expands Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Oct 2007
N30 Pharma Announces License Agreement With NitroMed, Inc.
Biopharmaceuticals Licensing

HSMN NewsFeed - 25 Oct 2007
Aradigm Corporation Reports Initial Human Data on a Novel Approach to Treatment of Tobacco Smoking Addiction Using its AERx Essence(R) Nicotine Inhaler
Devices Drug Delivery

HSMN NewsFeed - 22 Oct 2007
Study Using PARI Nebulizer Finds COPD Therapy of Nebulizer and Inhaler Combo More Effective than Inhaler Alone
Devices Drug Delivery

HSMN NewsFeed - 4 Oct 2007
Gilead Announces Detailed Results of Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 25 Sep 2007
Critical Therapeutics Highlights Near-Term Milestones to Drive Commercial Success and Clinical Development
Biopharmaceuticals

HSMN NewsFeed - 18 Sep 2007
Children's Hospital & Research Center Oakland Brings Portable CT Scanning to Pediatric Patients
Devices Radiology Neurology

HSMN NewsFeed - 18 Sep 2007
Study Demonstrates Aerosolized Prolastin(R) Using Unique Nebulizer Results in High Levels of Drug Deposited in Peripheral Regions of Lungs
Biopharmaceuticals Devices Drug Delivery

HSMN NewsFeed - 17 Sep 2007
Mpex Pharmaceuticals Names Dr. Jeffery Loutit as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Sep 2007
Aradigm and CyDex Sign Development Collaboration Agreement
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 21 Aug 2007
EPIX Pharmaceuticals Appoints Margaret Uprichard, Pharm.D. as Senior Vice President, Regulatory Affairs & Quality
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Aug 2007
Solvay Pharmaceuticals, Inc. Receives Approvable Letter from FDA with Respect to New Drug Application for CREON(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Aug 2007
InSite Vision Announces U.S. Launch of AzaSite(TM) for Ocular Infections
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 13 Aug 2007
Inspire Pharmaceuticals Launches AzaSite(TM) in the United States for Ocular Infections
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 10 Aug 2007
MAP Pharmaceuticals Promotes Stephen B. Shrewsbury to Position of Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Aug 2007
Bayer HealthCare and Nektar Therapeutics Launch Global Development and Commercialization Agreement to Fight Gram-Negative Pneumonias
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 2 Aug 2007
Axcan Pharma Submits Complete New Drug Application for ULTRASE
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 5 Jul 2007
Aradigm Corporation Names Norman Halleen as Interim Chief Financial Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 20 Jun 2007
Inspire and FAES Farma Amend Bilastine Licensing Agreement
Biopharmaceuticals Licensing

HSMN NewsFeed - 19 Jun 2007
Eurand's Zentase(TM) Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
Biopharmaceuticals

HSMN NewsFeed - 12 Jun 2007
Eurand Files NDA for Zentase(TM) for Exocrine Pancreatic Insufficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Jun 2007
Altus Pharmaceuticals Reacquires European Development and Commercialization Rights to ALTU-135
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 7 Jun 2007
Inspire Adds Stephen D. Celestini as Senior Vice President and Chief Compliance Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jun 2007
Transave, Inc. Appoints Mich Soga as Chief Financial Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 5 Jun 2007
Aradigm Names D. Jeffery Grimes as General Counsel and Corporate Secretary
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 29 May 2007
Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 9 May 2007
Altus Pharmaceuticals Initiates Phase III Clinical Trials of ALTU-135 for Cystic Fibrosis Patients with Pancreatic Insufficiency
Biopharmaceuticals

HSMN NewsFeed - 27 Apr 2007
Inspire Announces FDA Approval Of AzaSite(TM)
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 24 Apr 2007
Luminex Licenses Cystic Fibrosis Gene Patent From John Hopkins University
Diagnostics Licensing

HSMN NewsFeed - 23 Apr 2007
Hemispherx and Armada Health Care enter Agreement to Launch Alferon N Injection(R) via Specialty Pharmacy Network
Biopharmaceuticals

HSMN NewsFeed - 19 Apr 2007
Gilead Announces Presentation of Positive Phase III Data on Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
Biopharmaceuticals Devices

HSMN NewsFeed - 17 Apr 2007
Nanogen Submits 510(K) for Cystic Fibrosis Genetic Assay and NanoChip(R) 400 System
Diagnostics FDA

HSMN NewsFeed - 10 Apr 2007
Emisphere Technologies, Inc. Appoints Michael V. Novinski as President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 9 Apr 2007
Innovative Pulmonary and PEGylation-Based Therapeutic Product Development Drives Business Strategy of Nektar Therapeutics
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Apr 2007
EPIX Provides Update Regarding Status of Vasovist(TM) Appeal
Biopharmaceuticals Radiology FDA

HSMN NewsFeed - 13 Mar 2007
PARI's Hydrate Receives FDA 510k Clearance
Devices FDA

HSMN NewsFeed - 28 Feb 2007
EPIX Pharmaceuticals Files Formal Appeal for Vasovist(TM) with the Center for Drug Evaluation and Research
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Feb 2007
Analysis of International Phase III Study of Avastin(R) Plus Chemotherapy Shows Improved Progression-Free Survival in Patients With Advanced Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Feb 2007
Inspire Announces Executive Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Feb 2007
Inspire Licenses AzaSite(TM) For Ocular Infections
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 5 Feb 2007
EPIX Pharmaceuticals Presents Data from Novel MRI Imaging Agent at the Society for Cardiovascular Magnetic Resonance Meeting
Biopharmaceuticals Radiology Cardiology

HSMN NewsFeed - 2 Feb 2007
Genentech Announces Positive Results from a Phase IV Study of Raptiva in Patients With Moderate-to-Severe Hand and Foot Psoriasis
Biopharmaceuticals Dermatology

HSMN NewsFeed - 2 Feb 2007
Veteran Pharmaceutical Executive Joins AerovectRx Corp. Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jan 2007
Quest Diagnostics Announces Licensing Agreement for Genetic Testing Technology to Screen for Most Common Inherited Mental Impairment, Fragile X Syndrome
Diagnostics Licensing

HSMN NewsFeed - 16 Jan 2007
Inspire Provides Cystic Fibrosis Clinical Program Update
Biopharmaceuticals

HSMN NewsFeed - 16 Jan 2007
Aradigm Receives FDA Orphan Drug Designation for Liposomal Ciprofloxacin for Bronchiectasis
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Jan 2007
Aerovance Names Mark L. Perry President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jan 2007
Inspire Announces Dry Eye Program Update
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 4 Jan 2007
Court Affirms $7 Million in Damages for Innogenetics in Patent Infringement Suit
Biopharmaceuticals Diagnostics Litigation

HSMN NewsFeed - 3 Jan 2007
Third Wave Submits 510(k) to FDA for InPlex(TM) Cystic Fibrosis Molecular Test
Diagnostics

HSMN NewsFeed - 19 Dec 2006
Gilead Announces Preliminary Results From Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 18 Dec 2006
Aerovance Adds Accomplished Product Commercialization Executive to Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Dec 2006
EPIX Pharmaceuticals to File Appeal with the Center for Drug Evaluation and Research for Vasovist(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Dec 2006
New England Journal of Medicine Publishes Data from Pivotal Study of Avastin Plus Chemotherapy in Most Common Type of Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Nov 2006
FDA Approves Herceptin(R) for the Adjuvant Treatment of HER2-Positive Node-Positive Breast Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 6 Nov 2006
EPIX Announces Canadian Approval of Vasovist(TM); Marks 30th Country in Which Vasovist is Approved for Marketing
Biopharmaceuticals Regulatory Radiology

HSMN NewsFeed - 3 Nov 2006
PTC Therapeutics Announces Positive Phase 2 Results For PTC124 in Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 1 Nov 2006
Inspire and FAES Farma Announce Licensing Agreement for New Oral Antihistamine to Target Allergy Market in United States and Canada
Biopharmaceuticals LIcensing

HSMN NewsFeed - 25 Oct 2006
Sequenom Expands Non-Invasive Prenatal Diagnostic Testing Opportunity
Diagnostics Licensing

HSMN NewsFeed - 21 Oct 2006
PTC Therapeutics Announces Encouraging Preliminary Phase 2 Results of PTC124 in Duchenne Muscular Dystrophy
Biopharmaceuticals

HSMN NewsFeed - 19 Oct 2006
FDA Awards PTC Therapeutics Orphan Products Development Grant for the Development of PTC124 in Duchenne Muscular Dystrophy
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Oct 2006
KaloBios Pharmaceuticals Appoints David W. Pritchard as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Oct 2006
Transave, Inc. Appoints Renu Gupta, M.D. Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Oct 2006
New England Journal of Medicine Publishes Data From Lucentis Pivotal Phase III Studies in Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 4 Oct 2006
Eurand Announces License Agreement with GlaxoSmithKline
Biopharmaceuticals Licensing

HSMN NewsFeed - 1 Oct 2006
Jason M. Aryeh Elected to Ligand Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Sep 2006
FDA Approves Two New Indications for Rituxan(R) in Patients With Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 22 Sep 2006
Pharmaxis Board Change
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Sep 2006
EPIX Pharmaceuticals Announces Top-line Results from Phase 3 Trial of PRX-00023 in Generalized Anxiety Disorder
Biopharmaceuticals

HSMN NewsFeed - 20 Sep 2006
EPIX Announces Australian Approval of Vasovist(TM)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 8 Sep 2006
Jury Finds Abbott Willfully Infringed Innogenetics HCV Patent
Diagnostics Litigation

HSMN NewsFeed - 11 Jul 2006
Solvay Pharmaceuticals Settles Lawsuit Against Pseudo-Generic to CREON(R) MINIMICROSPHERES(R)
Biopharmaceuticals Litigation

HSMN NewsFeed - 5 Jul 2006
Aradigm and Novo Nordisk Execute Further Restructuring of Partnership
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 30 Jun 2006
FDA Approves LUCENTIS for the Treatment of Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 30 May 2006
FoldRx Pharmaceuticals Closes $43 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 May 2006
Genentech Submits Supplemental Biologics License Application for Avastin With Chemotherapy in First-Line Metastatic Breast Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 23 May 2006
Recruitment to Resume in Avastin International Phase III Trial (AVANT) in Early-Stage Colon Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 May 2006
Axcan Pharma appoints new Senior Vice President and Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 May 2006
Aradigm Receives FDA Orphan Drug Designation of Liposomal Ciprofloxacin for Cystic Fibrosis
Biopharmaceuticals FDA

HSMN NewsFeed - 4 May 2006
Aerovance Secures $60 Million in Financing
Biopharmaceuticals Venture Capital

Return to NewsFeed

Additional items found! 168

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 168 additional stories matching:
cystic fibrosis
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.